According to Stifel, the prior rating for Clearside Biomedical Inc (NASDAQ:CLSD) was changed from Hold to Buy. In the third quarter, Clearside Biomedical showed an EPS of $0.13, compared to $0.08 from the year-ago quarter. The current stock performance of Clearside Biomedical shows a 52-week-high of $2.95 and a 52-week-low of $1.00. Moreover, at the end of the last trading period, the closing price was at $1.28.

For Clearside Biomedical Inc (NASDAQ:CLSD), Needham upgraded the previous rating of Hold to Buy. In the third quarter, Clearside Biomedical showed an EPS of $0.13, compared to $0.08 from the year-ago quarter. The current stock performance of Clearside Biomedical shows a 52-week-high of $2.95 and a 52-week-low of $1.00. Moreover, at the end of the last trading period, the closing price was at $1.28.

For Purple Innovation Inc (NASDAQ:PRPL), Craig-Hallum upgraded the previous rating of Hold to Buy. In the third quarter, Purple Innovation showed an EPS of $0.03, compared to $0.07 from the year-ago quarter. The current stock performance of Purple Innovation shows a 52-week-high of $13.84 and a 52-week-low of $2.65. Moreover, at the end of the last trading period, the closing price was at $3.41.

According to RBC Capital, the prior rating for Scienjoy Holding Corp (NASDAQ:SJ) was changed from Sector Perform to Outperform. In the second quarter, Scienjoy Holding showed an EPS of $0.24, compared to $0.47 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.30 and a 52-week-low of $1.25. Scienjoy Holding closed at $1.59 at the end of the last trading period.

According to Raymond James, the prior rating for Activision Blizzard Inc (NASDAQ:ATVI) was changed from Market Perform to Outperform. Activision Blizzard earned $0.68 in the third quarter, compared to $0.72 in the year-ago quarter. The stock has a 52-week-high of $86.90 and a 52-week-low of $61.99. At the end of the last trading period, Activision Blizzard closed at $71.66.

According to Loop Capital, the prior rating for Palo Alto Networks Inc (NASDAQ:PANW) was changed from Hold to Buy. For the fourth quarter, Palo Alto Networks had an EPS of $0.80, compared to year-ago quarter EPS of $0.53. At the moment, the stock has a 52-week-high of $213.63 and a 52-week-low of $140.07. Palo Alto Networks closed at $151.57 at the end of the last trading period.

Piper Sandler upgraded the previous rating for KORU Medical Systems Inc (NASDAQ:KRMD) from Neutral to Overweight. For the third quarter, KORU Medical Systems had an EPS of $0.03, compared to year-ago quarter EPS of $0.02. The stock has a 52-week-high of $3.54 and a 52-week-low of $1.82. At the end of the last trading period, KORU Medical Systems closed at $2.31.

According to Raymond James, the prior rating for AeroVironment Inc (NASDAQ:AVAV) was changed from Market Perform to Outperform. AeroVironment earned $0.10 in the first quarter, compared to $0.17 in the year-ago quarter. The current stock performance of AeroVironment shows a 52-week-high of $114.11 and a 52-week-low of $52.03. Moreover, at the end of the last trading period, the closing price was at $81.52.

According to Goldman Sachs, the prior rating for Bentley Systems Inc (NASDAQ:BSY) was changed from Neutral to Buy. In the third quarter, Bentley Systems showed an EPS of $0.19, compared to $0.17 from the year-ago quarter. The current stock performance of Bentley Systems shows a 52-week-high of $48.91 and a 52-week-low of $26.32. Moreover, at the end of the last trading period, the closing price was at $34.43.

According to Credit Suisse, the prior rating for SunPower Corp (NASDAQ:SPWR) was changed from Underperform to Neutral. For the third quarter, SunPower had an EPS of $0.13, compared to year-ago quarter EPS of $0.06. The current stock performance of SunPower shows a 52-week-high of $28.42 and a 52-week-low of $12.78. Moreover, at the end of the last trading period, the closing price was at $19.15.

William Blair downgraded the previous rating for Primerica Inc (NYSE:PRI) from Outperform to Market Perform. For the third quarter, Primerica had an EPS of $3.02, compared to year-ago quarter EPS of $2.98. The current stock performance of Primerica shows a 52-week-high of $159.47 and a 52-week-low of $110.22. Moreover, at the end of the last trading period, the closing price was at $138.71.

Needham downgraded the previous rating for Rockley Photonics Holdings Ltd (NYSE:RKLY) from Buy to Hold. In the third quarter, Rockley Photonics Hldgs showed an EPS of $0.14, compared to $0.48 from the year-ago quarter. The current stock performance of Rockley Photonics Hldgs shows a 52-week-high of $5.14 and a 52-week-low of $0.37. Moreover, at the end of the last trading period, the closing price was at $0.37.

According to HC Wainwright & Co., the prior rating for Minerva Neurosciences Inc (NASDAQ:NERV) was changed from Buy to Neutral. In the third quarter, Minerva Neurosciences showed an EPS of $1.29, compared to $1.72 from the year-ago quarter. At the moment, the stock has a 52-week-high of $15.27 and a 52-week-low of $0.33. Minerva Neurosciences closed at $3.26 at the end of the last trading period.

For TechTarget Inc (NASDAQ:TTGT), Deutsche Bank downgraded the previous rating of Buy to Hold. For the third quarter, TechTarget had an EPS of $0.68, compared to year-ago quarter EPS of $0.60. The current stock performance of TechTarget shows a 52-week-high of $97.85 and a 52-week-low of $50.39. Moreover, at the end of the last trading period, the closing price was at $50.69.

For Rigetti Computing Inc (NASDAQ:RGTI), Benchmark downgraded the previous rating of Buy to Hold. In the second quarter, Rigetti Computing showed an EPS of $0.09, compared to $0.46 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.37 and a 52-week-low of $0.98. Rigetti Computing closed at $1.11 at the end of the last trading period.

According to Benchmark, the prior rating for ATI Physical Therapy Inc (NYSE:ATIP) was changed from Buy to Hold. ATI Physical Therapy earned $0.08 in the third quarter, compared to $1.68 in the year-ago quarter. At the moment, the stock has a 52-week-high of $3.93 and a 52-week-low of $0.58. ATI Physical Therapy closed at $0.66 at the end of the last trading period.

For Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT), Baird downgraded the previous rating of Neutral to Underperform. Arcturus Therapeutics earned $1.33 in the third quarter, compared to $2.05 in the year-ago quarter. The current stock performance of Arcturus Therapeutics shows a 52-week-high of $40.00 and a 52-week-low of $11.70. Moreover, at the end of the last trading period, the closing price was at $21.09.

JP Morgan downgraded the previous rating for Amyris Inc (NASDAQ:AMRS) from Neutral to Underweight. In the third quarter, Amyris showed an EPS of $0.44, compared to $0.27 from the year-ago quarter. The current stock performance of Amyris shows a 52-week-high of $6.37 and a 52-week-low of $1.44. Moreover, at the end of the last trading period, the closing price was at $1.51.

JP Morgan downgraded the previous rating for Elevation Oncology Inc (NASDAQ:ELEV) from Neutral to Underweight. In the third quarter, Elevation Oncology showed an EPS of $1.67, compared to $0.53 from the year-ago quarter. The stock has a 52-week-high of $6.87 and a 52-week-low of $0.90. At the end of the last trading period, Elevation Oncology closed at $0.90.

For PARTS iD Inc (AMEX:ID), Canaccord Genuity downgraded the previous rating of Buy to Hold. For the third quarter, PARTS iD had an EPS of $0.18, compared to year-ago quarter EPS of $0.10. The current stock performance of PARTS iD shows a 52-week-high of $2.50 and a 52-week-low of $0.86. Moreover, at the end of the last trading period, the closing price was at $1.54.

For Cano Health Inc (NYSE:CANO), Raymond James downgraded the previous rating of Outperform to Market Perform. Cano Health earned $0.23 in the third quarter, compared to $0.14 in the year-ago quarter. The current stock performance of Cano Health shows a 52-week-high of $9.75 and a 52-week-low of $3.30. Moreover, at the end of the last trading period, the closing price was at $3.34.

According to Jefferies, the prior rating for Apellis Pharmaceuticals Inc (NASDAQ:APLS) was changed from Buy to Hold. Apellis Pharmaceuticals earned $1.75 in the third quarter, compared to $1.57 in the year-ago quarter. The current stock performance of Apellis Pharmaceuticals shows a 52-week-high of $70.00 and a 52-week-low of $33.32. Moreover, at the end of the last trading period, the closing price was at $43.99.

According to JP Morgan, the prior rating for Roblox Corp (NYSE:RBLX) was changed from Overweight to Neutral. Roblox earned $0.50 in the third quarter, compared to $0.13 in the year-ago quarter. The current stock performance of Roblox shows a 52-week-high of $103.79 and a 52-week-low of $21.65. Moreover, at the end of the last trading period, the closing price was at $30.92.

For CytomX Therapeutics Inc (NASDAQ:CTMX), JP Morgan downgraded the previous rating of Overweight to Underweight. For the third quarter, CytomX Therapeutics had an EPS of $0.35, compared to year-ago quarter EPS of $0.35. The current stock performance of CytomX Therapeutics shows a 52-week-high of $4.73 and a 52-week-low of $1.17. Moreover, at the end of the last trading period, the closing price was at $1.24.

Morgan Stanley initiated coverage on ProKidney Corp (NASDAQ:PROK) with a Equal-Weight rating. The price target for ProKidney is set to $13.00. In the second quarter, ProKidney showed an EPS of $0.12, compared to $0.09 from the year-ago quarter. The current stock performance of ProKidney shows a 52-week-high of $11.98 and a 52-week-low of $6.19. Moreover, at the end of the last trading period, the closing price was at $10.55.

With a Neutral rating, Goldman Sachs initiated coverage on Tyler Technologies Inc (NYSE:TYL). The price target seems to have been set at $322.00 for Tyler Technologies. In the third quarter, Tyler Technologies showed an EPS of $2.06, compared to $2.01 from the year-ago quarter. At the moment, the stock has a 52-week-high of $538.96 and a 52-week-low of $281.11. Tyler Technologies closed at $292.02 at the end of the last trading period.